The use of the drug everolimus to reduce hypertrophy of the heart?s left ventricle in kidney transplant recipients

Completed

• Conditions: on diabetic patients receiving kidney transplants; Surgery

• Registration Number: ISRCTN93681079
• Lead Sponsor: San Martino University Hospital (Azienda Ospedaliera Universitaria San Martino) (Italy)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04-08
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Non diabetic renal transplant recipients (RTRs)

Exclusion Criteria

1. Patients receiving second transplant
2. Patients receiving dual transplant
3. Diabetic patients
4. Patients with severe cardiac valvular abnormalities

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in left ventricular mass index which is assessed by echocardiography after 1 year

Secondary Outcome Measures

Name	Time	Method
1. Changes in renal graft function at one and three years<br>2. Incidence of acute rejection episodes at one and three years